Phase II multicentre randomised study of docetaxel plus epirubicin vs 5-fluorouracil plus epirubicin and cyclophosphamide in metastatic breast cancer (Q36695861)
Jump to navigation
Jump to search
scientific article published on October 2004
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II multicentre randomised study of docetaxel plus epirubicin vs 5-fluorouracil plus epirubicin and cyclophosphamide in metastatic breast cancer |
scientific article published on October 2004 |
Statements
1 reference
Phase II multicentre randomised study of docetaxel plus epirubicin vs 5-fluorouracil plus epirubicin and cyclophosphamide in metastatic breast cancer (English)
1 reference
J Bonneterre
1 reference
V Dieras
1 reference
M Tubiana-Hulin
1 reference
P Bougnoux
1 reference
M-E Bonneterre
1 reference
T Delozier
1 reference
F Mayer
1 reference
S Culine
1 reference
N Dohoulou
1 reference
B Bendahmane
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference